OCC 1.10% 46.0¢ orthocell limited

Ann: CelGro Nerve Regeneration Results in Quadriplegic Patients, page-14

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 46 Posts.
    lightbulb Created with Sketch. 3
    'CelGro resulted in predictable and consistent restoration of muscle function'.

    very positive news. Go Orthocell !!
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.